id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
1527574,2403f9af-befb-43f2-aa95-e4e37bf37c09,Q1,GSK (FKA GLAXOSMITHKLINE INC.),16293,GSK (FKA GLAXOSMITHKLINE INC.),2014,first_quarter,TAX,"No bill # assigned - Tax reform policy issues, provisions related to corporate tax reform and research and development tax credit","Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)",,1630000,0,0,2014-04-18T14:11:03.963000-04:00